{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:12:05Z","timestamp":1778004725965,"version":"3.51.4"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Prevention and control for Emerging and Major Infectious Diseases- National Science and Technology Major Project, China","award":["2025ZD01905002"],"award-info":[{"award-number":["2025ZD01905002"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>HIV-associated talaromycosis (HAT) is a severe fungal infection for which established severity assessment methods are lacking. The Sequential Organ Failure Assessment (SOFA) and quick SOFA (qSOFA) scores were evaluated in 464 patients with HAT to assess their associations with inflammatory markers, hospital stay, and 30-day mortality. SOFA scores were negatively correlated with blood culture positivity time (r\u2009=\u2009-0.470, P\u2009&lt;\u20090.001) and positively correlated with IL-6, IL-10, and CRP (all P\u2009&lt;\u20090.001). Patients with fungemia had higher SOFA scores (2.3\u2009\u00b1\u20092.4 vs. 1.2\u2009\u00b1\u20090.6, P\u2009&lt;\u20090.001). Mortality increased with qSOFA scores: 8.9% (score 0), 16.5% (score 1), and 55.0% (score \u22652; P\u2009&lt;\u20090.001). For SOFA, mortality was 4.5% (scores 0\u20131), 6.8% (2\u20133), 22.0% (4\u20135), 52.2% (6\u20137), and 85.7% (\u22658; P\u2009&lt;\u20090.001), repectively. Survivors\u2019 SOFA scores improved by day 7 (1.6\u2009\u00b1\u20091.6 to 1.0\u2009\u00b1\u20091.4, P\u2009&lt;\u20090.001), while non-survivors worsened by day 7 (4.8\u2009\u00b1\u20093.4 to 5.1\u2009\u00b1\u20095.6, P\u2009=\u20090.027) compared to day 0. Among the surviving patients, the hospital stay days were 21.0 (14.0-27.0) for scores 0\u20131, 22.0 (16.0-29.0) for scores 2\u20133, 27.0 (20.3-43.5) for scores 4\u20136 and 29.0 (5.5-38.0) for scores \u22656 (P\u2009=\u20090.005). Multivariate analysis identified qSOFA [adjusted odds ratio (AOR):1.564, P\u2009=\u20090.018], SOFA [AOR:1.533, P\u2009=\u20090.001], and non-amphotericin B deoxycholate (non-AmBd) therapy [AOR:2.732, P\u2009=\u20090.026] were independent predictors of 30-day mortality. SOFA and qSOFA both predicted poor outcomes in patients with HAT. Early diagnosis and preemptive AmBd therapy should be prioritized for patients with HAT who had high SOFA\/qSOFA scores.<\/jats:p>","DOI":"10.1371\/journal.pntd.0014278","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:27:43Z","timestamp":1778002063000},"page":"e0014278","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequential Organ Failure Assessment (SOFA) score and quick SOFA(qSOFA) predict 30-day mortality in patients with HIV-associated Talaromycosis: A multicenter retrospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Guanjing","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguo","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dairong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-2086","authenticated-orcid":true,"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"7","key":"pntd.0014278.ref001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation","volume":"5","author":"G Casalini","year":"2024","journal-title":"Lancet Microbe"},{"issue":"11","key":"pntd.0014278.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(23)00174-1","article-title":"HIV and fungal priority pathogens","volume":"10","author":"H Sati","year":"2023","journal-title":"Lancet HIV"},{"issue":"1","key":"pntd.0014278.ref003","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00051-22","article-title":"An overlooked and underrated endemic mycosis-talaromycosis and the pathogenic fungus Talaromyces marneffei","volume":"36","author":"F Wang","year":"2023","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"pntd.0014278.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(21)00350-8","article-title":"A global call for talaromycosis to be recognised as a neglected tropical disease","volume":"9","author":"S Narayanasamy","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pntd.0014278.ref005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","article-title":"Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects","volume":"19","author":"N Vanittanakom","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"pntd.0014278.ref006","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"issue":"10229","key":"pntd.0014278.ref007","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"pntd.0014278.ref008","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/cid\/ciad100","article-title":"Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)","volume":"76","author":"M Falcone","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0014278.ref009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","article-title":"Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study","volume":"49","author":"A Tabah","year":"2023","journal-title":"Intensive Care Med"},{"issue":"11","key":"pntd.0014278.ref010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/hiv.13024","article-title":"Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017","volume":"21","author":"RS Ying","year":"2020","journal-title":"HIV Med"},{"issue":"12","key":"pntd.0014278.ref011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad593","article-title":"Aspartate aminotransferase\/platelet ratio index upon admission predicts 24-week mortality in patients with HIV-associated Talaromyces marneffei","volume":"10","author":"Q Wang","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"pntd.0014278.ref012","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30303-1","article-title":"Fungal infections in HIV\/AIDS","volume":"17","author":"AH Limper","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pntd.0014278.ref013","article-title":"Voriconazole is inferior to amphotericin B deoxycholate as the initial induction therapy for HIV-associated Talaromyces marneffei fungemia: a multicenter retrospective study","volume":"19","author":"S Ye","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"pntd.0014278.ref014","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","article-title":"Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition)","volume":"137","author":"Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"pntd.0014278.ref015","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/ciu094","article-title":"Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"H Masur","year":"2014","journal-title":"Clin Infect Dis"},{"key":"pntd.0014278.ref016","article-title":"Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09","author":"Z Dou","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"6","key":"pntd.0014278.ref017","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.chest.2024.01.015","article-title":"Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: a retrospective multicenter study","volume":"165","author":"R L\u00e9cuyer","year":"2024","journal-title":"Chest"},{"issue":"1","key":"pntd.0014278.ref018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","article-title":"Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study","volume":"9","author":"BJ Gaborit","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"13","key":"pntd.0014278.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34024","article-title":"Characteristics and risk factors for death in HIV-positive talaromycosis marneffei patients with sepsis","volume":"10","author":"M Wang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"pntd.0014278.ref020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-020-00798-x","article-title":"Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients","volume":"11","author":"J-R Lavillegrand","year":"2021","journal-title":"Ann Intensive Care"},{"key":"pntd.0014278.ref021","doi-asserted-by":"crossref","first-page":"868348","DOI":"10.3389\/fimmu.2022.868348","article-title":"Systemic inflammation evaluated by Interleukin-6 or C-reactive protein in critically ill patients: results from the FROG-ICU study","volume":"13","author":"A Picod","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"pntd.0014278.ref022","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.2016.20329","article-title":"Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department","volume":"317","author":"Y Freund","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"pntd.0014278.ref023","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"A Rhodes","year":"2017","journal-title":"Intensive Care Med"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:27:46Z","timestamp":1778002066000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014278"}},"subtitle":[],"editor":[{"given":"Marcio L","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014278","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}